Moreover, Krzyzanowska and colleagues showed that ADMA is a new indicator of cardiovascular risk in type 2 diabetics and that it, independently of other known risk factors, increases the predictive value of CRP for cardiovascular disease [22]. Here, CRP is linked to type 2 diabetes mellitus.